BIOMAT Database Logo BIOMAT Database Logo

Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. 1995

N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Biophysics Research Institute, Medical College of Wisconsin, Milwaukee 53226-0509, USA.

We have previously shown that nitric oxide donors inhibit the oxidation of low density lipoprotein (LDL) initiated by copper ions or by azo-bis-amidinopropane (Hogg et al., 1993. FEBS Lett. 334: 170-174). In this study, the nitric oxide donors S-nitroso-N-acetylpenicillamine (SNAP), spermine NONOate, and sodium nitroprusside were tested for their ability to inhibit macrophage-dependent oxidation of LDL. SNAP and spermine NONOate inhibited macrophage-dependent oxidation of LDL in a time- and concentration-dependent manner. We propose that nitric oxide is acting as a chain-breaking antioxidant that can inhibit the progression of lipid peroxidation in cell dependent-oxidation of LDL. By this mechanism nitric oxide could be an endogenous defense against atherogenesis. In contrast, sodium nitroprusside enhanced cell-mediated oxidation of LDL by a mechanism dependent on superoxide production and transition metal ions. Sodium nitroprusside also enhanced LDL oxidation by cell culture medium alone by a similar mechanism. The use of sodium nitroprusside as a nitric oxide donor in cellular systems appears to be complicated by the release of iron leading to an enhanced oxidative stress. Thus the effects of sodium nitroprusside in such systems may be unrelated to nitric oxide release.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009589 Nitrogen Oxides Inorganic oxides that contain nitrogen. Nitrogen Oxide,Oxide, Nitrogen,Oxides, Nitrogen
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013096 Spermine A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.

Related Publications

N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis.
July 1993, Atherosclerosis,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Nitric oxide and low-density lipoprotein oxidation.
June 1998, Free radical research,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
NOS1-derived nitric oxide facilitates macrophage uptake of low-density lipoprotein.
July 2019, Journal of cellular biochemistry,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
[Inhibitory effect of nitric oxide on oxidation of low-density lipoprotein].
September 2004, Nihon rinsho. Japanese journal of clinical medicine,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma.
May 1994, Journal of lipid research,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation.
January 1999, Methods in enzymology,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Inhibition of in vitro macrophage-induced low density lipoprotein oxidation by thyroid compounds.
April 2003, The Journal of endocrinology,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Inducible nitric oxide synthase knockout mouse and low-density lipoprotein oxidation.
January 2002, Methods in enzymology,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Inhibition of low-density lipoprotein oxidation by astaxanthin.
January 2000, Journal of atherosclerosis and thrombosis,
N Hogg, and A Struck, and S P Goss, and N Santanam, and J Joseph, and S Parthasarathy, and B Kalyanaraman
Inhibition of low-density lipoprotein and high-density lipoprotein oxidation by raloxifene.
May 2004, Journal of women's health (2002),
Copied contents to your clipboard!